原发灶不明转移癌基因表达谱分析技术进展  

Advances in gene expression profiling of metastases from unidentified primary tumor

作　　者：韩倩[1] 林连君[1] 刘新民[1] HAN Qian;LIN Lianjun;LIU Xinmin(Department of Geriatric, Peking University First Hospital ,Beijing 100034, China)

机构地区：[1]北京大学第一医院老年科,北京100034

出　　处：《实用肿瘤学杂志》2017年第6期554-558,共5页Practical Oncology Journal

摘　　要：原发灶不明转移癌(CUP)是一类经组织病理学证实为转移性,但经多种临床诊疗手段无法明确原发灶的肿瘤。明确肿瘤原发部位是CUP诊断的第一步,组织病理学、免疫组织化学技术、PET/CT都是临床常用的诊疗手段。基因表达谱分析技术是近年新兴的一种诊断原发灶的方法,具有较高的诊断准确率、敏感性和特异性,有望实现CUP患者的个体化治疗。Primary lesions unknown metastatic cancer（ CUP） is a class of histopathologically confirmed metastases. However,a variety of clinical diagnosis and treatment can not clear the primary tumor. The identification of tumor primary site is the first step in the diagnosis of CUP. The histopathology,immunohistochemistry and PET/CT are commonly used clinical diagnosis and treatment. Gene expression profiling technique is a new method for the diagnosis of primary tumor in recent years. It has high diagnostic accuracy,sensitivity and specificity,and is expected to achieve individual treatment of patients with CUP.

关 键 词：原发灶不明转移癌 基因表达谱分析技术 诊断进展 

分 类 号：R730.2[医药卫生—肿瘤]